EUVIMEDEUVIMED entdecken
Crossref

P53-armed Oncolytic Adenovirus Enhances the Efficacy of PD-1 Blockade in Neuroblastoma by Inducing Immunogenic Cell Death

Morimichi Tani, Hiroshi Tazawa, Terutaka Tanimoto, Hiroshi Nouso, Hinako Watanabe, Takanori Oyama, Yasuo Urata, Shunsuke Kagawa, Takuo Noda, Shinji Kuroda, Toshiyoshi Fujiwara

Anticancer Research · 2026-04 · 46 (4) · 1769-1784

DOI: 10.21873/anticanres.18073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 27.03.2026. Verfasst von Morimichi Tani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Hauptthemen laut MEDLINE: Neuroblastoma, Oncolytic Virotherapy, Adenoviridae, Oncolytic Viruses. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaOncolytic VirotherapyAdenoviridaeOncolytic VirusesProgrammed Cell Death 1 ReceptorImmunogenic Cell DeathTumor Suppressor Protein p53Immune Checkpoint InhibitorsHumansAnimalsMiceCell Line, TumorApoptosisHMGB1 ProteinCombined Modality TherapyFemaleXenograft Model Antitumor AssaysB7-H1 Antigen

Stichwörter der Autor:innen

NeuroblastomaPD-1immunogenic cell deathoncolytic adenovirusp53

Substanzen

Programmed Cell Death 1 ReceptorTumor Suppressor Protein p53Immune Checkpoint InhibitorsPDCD1 protein, humanTP53 protein, humanHMGB1 ProteinB7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Department of Pediatric Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; htazawa@md.okayama-u.ac.jp.
  • Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
  • Oncolys BioPharma, Inc., Tokyo, Japan.
  • Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Zitieren

APA

Tani, M., Tazawa, H., Tanimoto, T., Nouso, H., Watanabe, H., Oyama, T., Urata, Y., Kagawa, S., Noda, T., Kuroda, S., & Fujiwara, T. (2026). P53-armed Oncolytic Adenovirus Enhances the Efficacy of PD-1 Blockade in Neuroblastoma by Inducing Immunogenic Cell Death. Anticancer Research, 46(4), 1769-1784. https://doi.org/10.21873/anticanres.18073

Vancouver

Tani M, Tazawa H, Tanimoto T, Nouso H, Watanabe H, Oyama T, et al. P53-armed Oncolytic Adenovirus Enhances the Efficacy of PD-1 Blockade in Neuroblastoma by Inducing Immunogenic Cell Death. Anticancer Research. 2026;46(4):1769-1784. doi:10.21873/anticanres.18073

BibTeX
@article{Tani2026,
  author = {Tani, Morimichi and Tazawa, Hiroshi and Tanimoto, Terutaka and Nouso, Hiroshi and Watanabe, Hinako and Oyama, Takanori and Urata, Yasuo and Kagawa, Shunsuke and Noda, Takuo and Kuroda, Shinji and Fujiwara, Toshiyoshi},
  title = {P53-armed Oncolytic Adenovirus Enhances the Efficacy of PD-1 Blockade in Neuroblastoma by Inducing Immunogenic Cell Death},
  journal = {Anticancer Research},
  year = {2026},
  volume = {46},
  number = {4},
  pages = {1769--1784},
  doi = {10.21873/anticanres.18073}
}
Kostenlos starten →